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This is an educational case report including multiple choice
questions and their answers. For the best educational experience
we recommend the interactive web version of the exercisewhich
is available via the following link: http://www.oxfordjournals.
org/our_journals/omcr/ec01p1.html
Part 1
A 57 year-old male lorry driver, presented to his local emergency
department with a 20-minute episode of diaphoresis and chest
pain. The chest pain was central, radiating to the left arm and
crushing in nature. The pain settled promptly following 300 mg
aspirin orally and 800 mcg glyceryl trinitrate (GTN) spray sublin-
gually administered by paramedics in the community. He
smoked 20 cigarettes daily (38 pack years) but was not aware of
any other cardiovascular risk factors. On examination he ap-
peared comfortable and was able to complete sentences fully.
There were no heart murmurs present on cardiac auscultation.
Blood pressure was 180/105 mmHg, heart rate was 83 bpm and
regular, oxygen saturation was 97%.
What is the most likely diagnosis?
A Acute coronary syndrome
B Aortic dissection
C Esophageal rupture
D Peptic ulceration
E Pneumothorax
Part 2
An ECG was requested and is shown in ﬁgure 1.
Howwould youmanage the patient? (The patient has already re-
ceived 300 mg aspirin).
A Atenolol 25 mg, Atorvastatin 80 mg, Clopidogrel 75 mg,
GTN 500 mcg
B Atenolol 25 mg, Clopidogrel 75 mg, GTN 500 mcg,
Simvastatin 20 mg
C Atorvastatin 80 mg, Clopidogrel 300 mcg, GTN 500 mcg,
Ramipril 2.5 mg
D Atorvastatin 80 mg, Clopidogrel 75 mg, Diltiazem 60 mg,
Oxygen
E Clopidogrel 300 mg, Morphine 5 mg, Ramipril 2.5 mg,
Simvastatin 20 mg
Part 3
30minutes later the patient’s chest pain returnedwith greater in-
tensity whilst waiting in the emergency department. Now, he de-
scribed the pain as though “an elephant is sitting on his chest”.
The nurse has already done an ECG by the time you were called
to see him. This is shown in ﬁgure 2.
What would be the optimal management for this patient?
A Administer intravenous morphine
B Increase GTN dose
C Observe as no new signiﬁcant changes
D Proceed to coronary angiography
E Thrombolyse with alteplase
Part 4
He was taken to the catheterization lab where the left anterior
descending coronary artery (LAD) was shown to be completely
occluded. Following successful percutaneous intervention and
one drug eluding stent implantation in the LADnormal ﬂow is re-
stored (Thrombosis in myocardial infarction, TIMI = 3). 72 hours
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later, he is ready to be discharged home. The patient is keen to re-
turn to work and asks when he could do so.
When would you advise him that he could return to work?
A 1 week later
B 3 weeks later
C 6 weeks later
D Not before repeat angiography
E Not before an exercise test
Part 5
One week later, he receives a letter informing him that he is re-
quired to attend cardiac rehabilitation. The patient is confused
as to what cardiac rehabilitation entails, although he does re-
member a nurse discussing this with him brieﬂy before he was
discharged. He phones the hospital in order to get some more
information.
Figure 2: ECG 30 minutes after admission.
Figure 1: ECG on admission.
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Which of the following can be addressed during cardiac
rehabilitation?
A Diet
B Exercise
C Pharmacotherapy
D Smoking cessation
E All of the above
Answer to Part 1
A - Acute coronary syndrome
Although the presentation could be attributable to any of the
above differential diagnoses, the most likely etiology given the
clinical picture and risk factors is one of cardiac ischemia. Risk
factors include gender, smoking status and age making the diag-
nosis of acute coronary syndrome the most likely one. The broad
differential diagnosis in patients presenting with chest pain has
been discussed extensively in the medical literature. An old but
relevant review can be found freely available1 as well as more re-
cent reviews.2,3
Answer to Part 2
C - Atorvastatin 80 mg, Clopidogrel 300 mcg, GTN 500 mcg,
Ramipril 2.5 mg,
In patients with ACS, medications can be tailored to the indi-
vidual patient. Some medications have symptomatic beneﬁt but
some also have prognostic beneﬁt. Aspirin4 , Clopidogrel5 , Aten-
olol6 and Atorvastatin7 have been found to improve prognosis
signiﬁcantly. ACE inhibitors have also been found to improve
left ventricular modeling and function after an MI.8,9 Further-
more, GTN10 and morphine11 have been found to be of only sig-
niﬁcant symptomatic beneﬁt.
Oxygen should only to be used when saturations <95% and at
the lowest concentration required to keep saturations >95%.12
There is no evidence that diltiazem, a calcium channel
blocker, is of beneﬁt.13
His ECG inﬁgure 1does not fulﬁl STelevationmyocardial infarc-
tion (STEMI) criteria and he should therefore bemanaged as aNon-
STEMI.Hewouldbeneﬁtprognosticallyfrombeta-blockadehowever
hisheart rate isonly42bpmandthereforethis iscontraindicated.He
should receive a loading dose of clopidogrel (300 mg) followed by
daily maintenance dose (75 mg).14,15 He might not require GTN if
he is pain-free but out of the available answers 3 is themost correct.
Answer to Part 3
D - Proceed to coronary angiography
The ECG shows ST elevation in leads V2-V6 and conﬁrms an
anterolateral STEMI, which suggests a completely occluded LAD.
This ECG fulﬁls the criteria to initiate reperfusion therapy which
traditionally require one of the three to be present:
• ≥ 1 mm of ST change in at least two contiguous limb leads
(II, III, AVF, I, AVL).
• ≥ 2 mm of ST change in at least two contiguous chest leads
(V1-V6).
• New left bundle branch block.
According to guidance, if the patient can undergo coronary angi-
ography within 120 minutes from the onset of chest pain, then
this represents the optimal management. If it is not possible to
undergo coronary angiography and potentially percutaneous
intervention within 2 hours, then thrombolysis is considered
an acceptable alternative.12,16
GTN and morphine administration can be considered in par-
allel but they do not have a prognostic beneﬁt.
Answer to Part 4
E - Not before an exercise test
This patient is a lorry driver and therefore has a professional
heavy vehicle driving license. The regulation for driving initiation
in a lorry driver following aNSTEMI/ STEMImaybedifferent in vari-
ouscountriesandthereforethe local regulationsshouldbefollowed.
In the UK, a lorry driver holds a category 2 driving license. He
should therefore refrain from driving a lorry for at least 6 weeks
and can only return to driving if he completes successfully an
exercise evaluation. An exercise evaluation is performed on a
bicycle or treadmill. Drivers should be able to complete 3 stages
of the standard Bruce protocol17 or equivalent (e.g. Myocardial
perfusion scan) safely, having refrained from taking anti-angin-
al medication for 48 hours and should remain free from signs of
cardiovascular dysfunction during the test, notably: angina pec-
toris, syncope, hypotension, sustained ventricular tachycardia,
and/or electrocardiographic ST segment shift which is consid-
ered as being indicative of myocardial ischemia (usually >2
mmhorizontal or down-sloping) during exercise or the recovery
period.18
For a standard car driving license (category 1), driving can
resume one week after successful intervention providing that
no other revascularization is planned within 4 weeks; left ven-
tricular ejection fraction (LVEF) is at least 40% prior to hospital
discharge and there is no other disqualifying condition.
Therefore if this patent was in the UK, he could restart driving
a normal car one week later assuming an echocardiogram con-
ﬁrmed an EF > 40%. However, he could only continue lorry driving
once he has passed the required tests.18
Answer to Part 5
E - All of the above
Cardiac rehabilitation bridges the gap between hospitals and
patients’ homes. The cardiac rehabilitation team consists of vari-
ous healthcare professions and the programme is started during
hospital admission or after diagnosis. Its aim is to educate pa-
tients about their cardiac condition in order to help them adopt
a healthier lifestyle. This includes educating patients’ about
their diet, exercise, risk factors associated with their condition
such as smoking and alcohol intake and ﬁnally, about the medi-
cation recommended. There is good evidence that adherence to
cardiac rehabilitation programmes improves survival and leads
to a reduction in future cardiovascular events.19,20
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